{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:50:19Z","timestamp":1761515419376,"version":"build-2065373602"},"reference-count":25,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2007,7,1]],"date-time":"2007-07-01T00:00:00Z","timestamp":1183248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,7,1]],"date-time":"2007-07-01T00:00:00Z","timestamp":1183248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2007,7]]},"DOI":"10.4158\/ep.13.4.373","type":"journal-article","created":{"date-parts":[[2013,4,5]],"date-time":"2013-04-05T21:55:21Z","timestamp":1365198921000},"page":"373-379","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Changes in glucose tolerance with metformin treatment in polycystic ovary syndrome: A retrospective analysis"],"prefix":"10.1016","volume":"13","author":[{"given":"Susmeeta T.","family":"Sharma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"III","given":"Edmond P.","family":"Wickham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John E.","family":"Nestler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.4158\/EP.13.4.373_bb0005","first-page":"2434","article-title":"A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain","volume":"85","author":"Asuncion","year":"2000","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP.13.4.373_bb0010","first-page":"3078","article-title":"Prevalence of the poly- cystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study","volume":"83","author":"Knochenhauer","year":"1998","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP.13.4.373_bb0015","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1210\/jcem-57-2-356","article-title":"Insulin resistance in nonobese patients with polycystic ovarian disease","volume":"57","author":"Chang","year":"1983","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP.13.4.373_bb0020","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1210\/jcem-65-3-499","article-title":"Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance, and\/or hyperinsulinemia","volume":"65","author":"Dunaif","year":"1987","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP.13.4.373_bb0025","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.2337\/diab.38.9.1165","article-title":"Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome","volume":"38","author":"Dunaif","year":"1989","journal-title":"Diabetes."},{"key":"10.4158\/EP.13.4.373_bb0030","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.2337\/diab.41.10.1257","article-title":"Evidence for distinctive and intrinsic defects in insulin action in polycystic ovary syndrome","volume":"41","author":"Dunaif","year":"1992","journal-title":"Diabetes."},{"key":"10.4158\/EP.13.4.373_bb0035","first-page":"577","article-title":"el-Roeiy A, Madar Z, Reichart D, Olefsky JM, Yen SS. Cellular mechanisms of insulin resistance in polycystic ovarian syndrome","volume":"75","author":"Ciaraldi","year":"1992","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP.13.4.373_bb0040","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1172\/JCI118126","article-title":"Excessive insulin receptor serine phosphorylation in cultured fibroblasts and in skeletal muscle: a potential mechanism for insulin resistance in the polycystic ovary syndrome","volume":"96","author":"Dunaif","year":"1995","journal-title":"J Clin Invest."},{"key":"10.4158\/EP.13.4.373_bb0045","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3109\/09513599709152521","article-title":"A twin study of polycystic ovary syndrome and lipids","volume":"11","author":"Jahanfar","year":"1997","journal-title":"Gynecol Endocrinol."},{"key":"10.4158\/EP.13.4.373_bb0050","doi-asserted-by":"crossref","first-page":"300","DOI":"10.2337\/diacare.29.02.06.dc05-1070","article-title":"Altered D- chiro-inositol urinary clearance in women with polycystic ovary syndrome","volume":"29","author":"Baillargeon","year":"2006","journal-title":"Diabetes Care."},{"key":"10.4158\/EP.13.4.373_bb0055","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1210\/jcem-70-4-1114","article-title":"Impact of obesity on insulin action in volunteers with normal glucose tolerance: demonstration of a threshold for the adverse effect of obesity","volume":"70","author":"Campbell","year":"1990","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP.13.4.373_bb0060","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1056\/NEJM199312303292703","article-title":"Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus: prospective studies of Pima Indians","volume":"329","author":"Lillioja","year":"1993","journal-title":"N Engl J Med."},{"key":"10.4158\/EP.13.4.373_bb0065","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0899-9007(97)90878-9","article-title":"Banting Lecture 1988: role of insulin resistance in human disease; 1988","volume":"13","author":"Reaven","year":"1997","journal-title":"Nutrition."},{"key":"10.4158\/EP.13.4.373_bb0070","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2337\/diacare.22.1.141","article-title":"Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome","volume":"22","author":"Ehrmann","year":"1999","journal-title":"Diabetes Care."},{"key":"10.4158\/EP.13.4.373_bb0075","doi-asserted-by":"crossref","first-page":"518","DOI":"10.2337\/diacare.21.4.518","article-title":"Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults: the Third National Health and Nutrition Examination Survey, 1988-1994","volume":"21","author":"Harris","year":"1998","journal-title":"Diabetes Care."},{"key":"10.4158\/EP.13.4.373_bb0080","first-page":"165","article-title":"Prevalence and predictors of risk for type 2 diabetes melli-tus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women","volume":"84","author":"Legro","year":"1999","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP.13.4.373_bb0085","doi-asserted-by":"crossref","first-page":"3236","DOI":"10.1210\/jc.2004-1843","article-title":"Changes in glucose tolerance over time in women with polycystic ovary syndrome: a controlled study","volume":"90","author":"Legro","year":"2005","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP.13.4.373_bb0090","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMoa012512","article-title":"(Diabetes Prevention Program Research Group). Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin","volume":"346","author":"Knowler","year":"2002","journal-title":"N Engl J Med."},{"key":"10.4158\/EP.13.4.373_bb0095","series-title":"Polycystic Ovary Syndrome: Current Issues in Endocrinology","first-page":"377","article-title":"Diagnostic criteria for polycystic ovary syndrome: towards a rational approach","volume":"4","author":"Zawadzki","year":"1992"},{"key":"10.4158\/EP.13.4.373_bb0100","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.2337\/diacare.26.11.3160","article-title":"(Expert Committee on the Diagnosis and Classification of Diabetes Mellitus). Follow-up report on the diagnosis of diabetes mellitus","volume":"26","author":"Genuth","year":"2003","journal-title":"Diabetes Care."},{"key":"10.4158\/EP.13.4.373_bb0105","first-page":"3327","article-title":"Metabolic effects of oral contraceptives in women with polycystic ovary syndrome","volume":"80","author":"Korytkowski","year":"1995","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP.13.4.373_bb0110","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1007\/BF00401427","article-title":"Oral contra ceptive use and the risk of type 2 (non-insulin-dependent) diabetes mellitus in a large prospective study of women","volume":"35","author":"Rimm","year":"1992","journal-title":"Diabetologia."},{"key":"10.4158\/EP.13.4.373_bb0115","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.2337\/diacare.21.10.1686","article-title":"The 1997 American Diabetes Association criteria versus the 1985 World Health Organization criteria for the diagnosis of abnormal glucose tolerance: poor agreement in the Hoorn Study","volume":"21","author":"de Vegt","year":"1998","journal-title":"Diabetes Care."},{"key":"10.4158\/EP.13.4.373_bb0120","first-page":"1886","article-title":"Lopez- Alvarenga JC, Perez-Jauregui J, Guillen-Pineda LE","volume":"21","author":"Gomez-Perez","year":"1998","journal-title":"Rull JA. Lack of agreement between the World Health Organization category of impaired glucose tolerance and the American Diabetes Association category of impaired fasting glucose. Diabetes Care."},{"key":"10.4158\/EP.13.4.373_bb0125","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1210\/jcem.87.3.8305","article-title":"Screening for abnormal glucose tolerance in adolescents with polycystic ovary syndrome","volume":"87","author":"Palmert","year":"2002","journal-title":"J Clin Endocrinol Metab."}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20418543?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20418543?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/aace.metapress.com\/index\/5J2K4U8873236646.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:47:03Z","timestamp":1761515223000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X20418543"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,7]]}},"alternative-id":["S1530891X20418543"],"URL":"https:\/\/doi.org\/10.4158\/ep.13.4.373","relation":{},"ISSN":["1530-891X"],"issn-type":[{"type":"print","value":"1530-891X"}],"subject":[],"published":{"date-parts":[[2007,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Changes in glucose tolerance with metformin treatment in polycystic ovary syndrome: A retrospective analysis","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP.13.4.373","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}